PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29217817-0	2017	Acetazolamide Suppresses Multi-Drug Resistance-Related Protein 1 and P-Glycoprotein Expression by Inhibiting Aquaporins Expression in a Mesial Temporal Epilepsy Rat Model.	Acetazolamide	0-13	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	69-83	
29217817-5	2017	The other 18 MTLE model rats were used to observe the effects of the AQP4 inhibitor, acetazolamide, on the multi-drug-resistant protein 1 (MRP1) and P-glycoprotein (Pgp) by using Western blot and immunohistochemistry assays, respectively.	Acetazolamide	85-98	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	149-163	
29217817-5	2017	The other 18 MTLE model rats were used to observe the effects of the AQP4 inhibitor, acetazolamide, on the multi-drug-resistant protein 1 (MRP1) and P-glycoprotein (Pgp) by using Western blot and immunohistochemistry assays, respectively.	Acetazolamide	85-98	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	165-168	
29217817-9	2017	CONCLUSIONS The present findings confirm that the AQP4 inhibitor, acetazolamide, effectively inhibits the multi-drug-resistant protein, MRP1, and Pgp, in the MTLE rat model.	Acetazolamide	66-79	ATP-binding cassette, subfamily B (MDR/TAP), member 1B	Rattus norvegicus	146-149